Prince Pharmaceutical Co., Ltd. - ROE
6935.TWO
Price:
$28.5
Market Cap:
$1.07B
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac,...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2023-03-29
Stock Exchange
TWO
Ticker
6935.TWO
PE Ratio
[10.92]
ROE
[15.22%]
Current Ratio
[1.69]
Dividend Yield
[1.74%]
Enterprise Value
[1.25B]
Dividend History
The ROE as of September 2026 (TTM) for Prince Pharmaceutical Co., Ltd. (6935.TWO) is 15.22%
According to Prince Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 15.22%. This represents a change of 344.09% compared to the average of 3.43% of the last 4 quarters.
Prince Pharmaceutical Co., Ltd. (6935.TWO) Historical ROE (quarterly & annually)
How has 6935.TWO ROE performed in the past?
The mean historical ROE of Prince Pharmaceutical Co., Ltd. over the last ten years is 1.00%. The current 15.22% ROE has changed 1.43% with respect to the historical average. Over the past ten years (40 quarters), 6935.TWO's ROE was at its highest in in the December 2025 quarter at 9.37%. The ROE was at its lowest in in the December 2024 quarter at -3.98%.
Average
1.00%
Median
0.00%
Minimum
-7.42%
Maximum
11.48%
Prince Pharmaceutical Co., Ltd. (6935.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Prince Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 11.48%
Minimum Annual Increase = -381099.16%
Minimum Annual ROE = -7.42%
| Year | ROE | Change |
|---|---|---|
| 2025 | 11.48% | -254.88% |
| 2024 | -7.42% | -475.13% |
| 2023 | 1.98% | -74.76% |
| 2022 | 7.83% | -668.63% |
| 2021 | -1.38% | -75.12% |
| 2020 | -5.53% | -381099.16% |
Prince Pharmaceutical Co., Ltd. (6935.TWO) Average ROE
How has 6935.TWO ROE performed in the past?
The current ROE of Prince Pharmaceutical Co., Ltd. (6935.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.02%
5-year avg
2.50%
10-year avg
1.00%
Prince Pharmaceutical Co., Ltd. (6935.TWO) ROE vs. Peers
How is 6935.TWO’s ROE compared to its peers?
Prince Pharmaceutical Co., Ltd.’s ROE is less than DV Biomed Co., Ltd. (14.50%), greater than Excelsior Biopharma Inc. (-26.78%), greater than Anxo Pharmaceutical Co., Ltd. (-2.07%), greater than Puriblood Medical Co., Ltd. (-44.72%), greater than Lukas Biomedical Inc. (-42.67%), less than Tien Liang BioTech Co., Ltd. (13.99%), greater than Bio Preventive Medicine Corp. (-34.62%), greater than Wiltrom Co., Ltd. (-2.97%), greater than NeoCore Technology Co., Ltd. (-12.10%), greater than LabTurbo Biotech Corporation (-3.36%),
| Company | ROE | Market cap |
|---|---|---|
| 14.50% | $999.54M | |
| -26.78% | $1.13B | |
| -2.07% | $951.66M | |
| -44.72% | $1.05B | |
| -42.67% | $766.29M | |
| 13.99% | $2.86B | |
| -34.62% | $1.02B | |
| -2.97% | $965.88M | |
| -12.10% | $1.27B | |
| -3.36% | $1.10B |
Build a custom stock screener for Prince Pharmaceutical Co., Ltd. (6935.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prince Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Prince Pharmaceutical Co., Ltd. (6935.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Prince Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Prince Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the highest ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the 3-year average ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the 5-year average ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
How does the current ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO) compare to its historical average?